List of Excipients in API methamphetamine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methamphetamine hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
RECORDATI RARE DISEASES INC | DESOXYN | methamphetamine hydrochloride | 55292-102 | AMINOBENZOATE SODIUM | |
RECORDATI RARE DISEASES INC | DESOXYN | methamphetamine hydrochloride | 55292-102 | LACTOSE | |
RECORDATI RARE DISEASES INC | DESOXYN | methamphetamine hydrochloride | 55292-102 | STARCH, CORN | |
RECORDATI RARE DISEASES INC | DESOXYN | methamphetamine hydrochloride | 55292-102 | STEARIC ACID | |
RECORDATI RARE DISEASES INC | DESOXYN | methamphetamine hydrochloride | 55292-102 | TALC | |
Key Therapeutics | DESOXYN | methamphetamine hydrochloride | 70868-820 | AMINOBENZOATE SODIUM | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing methamphetamine hydrochloride
Detailed excipient profiles for methamphetamine hydrochloride
Excipient focus: AMINOBENZOATE SODIUM
methamphetamine hydrochloride drug variants containing AMINOBENZOATE SODIUM
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing AMINOBENZOATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methamphetamine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
methamphetamine hydrochloride drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
methamphetamine hydrochloride drug variants containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
methamphetamine hydrochloride drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
methamphetamine hydrochloride drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
methamphetamine hydrochloride drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
methamphetamine hydrochloride drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
methamphetamine hydrochloride drug variants containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
methamphetamine hydrochloride drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
methamphetamine hydrochloride drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | methamphetamine hydrochloride | 0054-0389 |
>Company | >Ingredient | >NDC |
methamphetamine hydrochloride drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
RECORDATI RARE DISEASES INC | methamphetamine hydrochloride | 55292-102 |
Mayne Pharma Commercial LLC | methamphetamine hydrochloride | 68308-115 |
Key Therapeutics | methamphetamine hydrochloride | 70868-820 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.